Toxic epidermal necrolysis induced by the topical carbonic anhydrase inhibitors brinzolamide and dorzolamide

Annals of Dermatology

Volumn 20, Issue 4, 2008, Pages 260-262

  Chun, Ji Sun ^a   Yun, Sook Jung ^a   Lee, Jee Bum ^a   Kim, Seong Jin ^a   Won, Young Ho ^a   Lee, Seung Chul ^a  

^a Chonnam National University Medical School   (South Korea)

Author keywords

Brinzolamide; Dorzolamide; Toxic epidermal necrolysis

Indexed keywords

EID: 77952906962     PISSN: 10139087     EISSN: 20053894     Source Type: Journal    
DOI: 10.5021/ad.2008.20.4.260     Document Type: Article

References (10)

1. Cvetkovic RS, Perry CM. Brinzolamide: a review of its use in the management of primary open-angle glaucoma and ocular hypertension. Drugs Aging 2003;20:919-947. (Pubitemid 37340285)
2. Herkel U, Pfeiffer N. Update on topical carbonic anhydrase inhibitors. Curr Opin Ophthalmol 2001; 12:88-93. (Pubitemid 32232078)
3. Sulfonamide cross reactions explained. SDIS Drug News 2003;20(2):April-May.
4. DeSantis L. Preclinical overview of brinzolamide. Surv Ophthalmol 2000;44:S119-S129.
5. Mincione F, Scozzafava A, Supuran CT. The development of topically acting carbonic anhydrase inhibitors as anti-glaucoma agents. Curr Top Med Chem 2007;7:849-854. (Pubitemid 46825081)
6. Alcon (USA) Inc. Azopt® (brinzolamide ophthalmic suspension) 1%. Prescribing information [Internet]. Available from: http://ecatalog.alcon.com/ pi/Azopt-us-en.pdf.
7. Alcon Laboratories (UK) Ltd. Azopt (brinzolamide eye drops suspension) 1%. Summary of product characteristics. eMC [Internet]. Available from: http://emc.medicines.org.uk/emc/assets/c/html/displaydoc.asp?documentid=2808.
8. Florez A, Roson E, Conde A, Gonzalez B, Garcia- Doval I, de la Torre C, et al. Toxic epidermal necrolysis secondary to timolol, dorzolamide, and latanoprost eyedrops. J Am Acad Dermatol 2005; 53:909-911. (Pubitemid 41501400)
9. Radimer GF, Davis JH, Ackerman AB. Fumigantinduced toxic epidermal necrolysis. Arch Dermatol 1974;110:103-104.
10. Thompson JA Jr, Wansker BA. A case of contact dermatitis, erythema multiforme, and toxic epidermal necrolysis. J Am Acad Dermatol 1981;5: 666-669. (Pubitemid 12167284)